Side effects of olaparib for ovarian cancer

Modern women are under increasing pressure at work and at home, and long-term pressure has also increased the incidence of cancer. Although stress is only one of the reasons women are susceptible to ovarian cancer, it is undeniable that the incidence of the disease is indeed increasing year by year, and olaparib is a targeted drug for the treatment of ovarian cancer.

Like other cancers, there is no cure for ovarian cancer. Not only that, the prognosis of this disease is poor, the recurrence rate is low, and the survival rate within 5 years after recurrence is very low, so we cannot underestimate the disease.

There are no obvious features in the early stages of the disease. When symptoms appear, they are often in the middle and late stages. Therefore, to improve the survival rate, we must pay attention to early inspection. The physical examination was quickly used as a diagnosis. If you find any abnormalities, don't be too alarmed, actively seek treatment, and discuss treatment options with your doctor. Today, with the gradual improvement of medical technology, you must have confidence in the treatment, which also helps to achieve better treatment results.

Olapani is a targeted drug for the treatment of ovarian cancer. Currently known side effects are: anemia, nausea and vomiting, abdominal pain, diarrhea and myelodysplastic syndrome. Compared with other systemic chemotherapy drugs, its side effects are relatively small.